The Biotechnology Innovation Organization (BIO) presents this webinar to hear from top Big Pharma professionals in search & evaluation licensing and venture investing about what it takes to get them interested in a new technology. We look at their recent deals and ask why they got done, explore the challenges and learn what makes a technology exciting. Then we dive into a discussion on what tech/modalities and platforms are seen as exciting. Finally, we get advice for those biotechs that are ready for licensing or investment.
Big Pharma’s View of Emerging Tech for Partnership & Investment
May 26, 2022
Moderators & Speakers
Linda Pullan, Moderator
Search & Evaluation , Oncology Lead
Neuroscience Search & Evaluation, Eli Lilly & Co.
Head,Headquarters Search & Evaluation
Merck & Co.
Sr. Director, External Science & Innovation